The Spring 2026 Newsletter highlights Easton Center advances in Alzheimer’s research through engineering & AI, plus insights on hormone therapy and risk.
Researchers at UCLA used UCLA ATLAS to reveal ancestry specific disease risk and semaglutide response—demonstrating the importance of diverse biobanks ...
Drs. Alejandra Sánchez López and Jason Hinman, co-authored in the JAGS, note that blood based biomarkers can detect Alzheimer’s disease biology, but ...
The Winter 2026 Newsletter highlights how the Easton Center is accelerating Alzheimer’s research through philanthropy and innovation, featuring perspectives ..
1 min read
In an interview with ABC7 Eyewitness News, UCLA neurologist Dr. Timothy Chang explains how a new AI tool is transforming the early detection of Alzheimer’s disease. Image courtesy of ABC7.
Dr. Timothy Chang, UCLA neurologist, explained how early diagnosis is critical for patient care and access to new therapies and that AI could help identify..
The Autumn 2025 Newsletter features Dr. Jason Hinman, the Easton Center Director, with a clear vision to lead the next era of Alzheimer’s discovery and care...
The Summer 2025 Newsletter features the Alzheimer’s Association® 2025 Facts & Figures report on early detection and new treatments, plus BEAM at UCLA...
The Winter 2025 Newsletter features a note from the Director(s) regarding the launch of the UCLA Amyloid Immunotherapy Care Program, the two successful...
The Autumn 2024 Newsletter highlights Dr. Marie Kim’s answers to FAQs about donenamab and lecanemab, an overview of the 2024 Facts and Figures Report, and...
